Photo of Darrell C. Tucker II

Darrell Tucker is focused on representing construction, insurance, and pharmaceutical and medical device companies in commercial disputes, class actions and mass tort litigation. Darrell is known for his ability to understand the industry-specific details inherent in the often multi-faceted process of complex litigation. He represents his clients in numerous states, counseling them on risk management, litigation-related due diligence, and preparing and defending witnesses for depositions. He represents life, health, and disability insurers in disputes concerning denials of benefits (including life, disability, long term care, and cancer benefits), rescission and termination issues, ERISA claims, insurance fraud, interpleader actions, insurance agent/agency termination and compensation claims, and class actions involving insurance policy terms and determination of claims.

Alabama’s Act Aimed at Prohibiting Financial Abuse of Elders – Should It Be Expanded to Cover Insurers and Insurance Agents?Alabama’s Elder Abuse Act attempts to protect financial abuse of elders. But by not including insurance companies and insurance agents, does the Act go far enough?

Following up on the blog post from late June concerning the intersection of elder abuse laws and long-term care litigation, this post concerns an Alabama statute aiming to prevent

Ninth Circuit Affirms Denial of Motion to Compel Arbitration of ERISA ActionIn Munro v. Univ. of S. Cal., the Ninth Circuit recently affirmed the district court’s denial of a motion to compel arbitration of an ERISA action brought by current and former employees of the University of Southern California (USC). The employees alleged that USC, as administrator of certain employee retirement plans, had breached

Blue Cross Blue Shield MDL Judge Certifies Appeal of Summary Judgment RulingOn June 12, 2018, Judge David Proctor certified a “pure question of law” to the Eleventh Circuit in the Blue Cross Blue Shield Antitrust Litigation, which could “materially advance the ultimate termination of this litigation.”

The Blue Cross Blue Shield Antitrust Litigation MDL, pending since approximately 2013, involves “allegations by two separate putative class